homefeedbacksupportlog on 6-Jul-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


Varun Garg
Department of Clinical Pharmacology, Vertex Pharmaceuticals, Cambridge, United States of America

Faculty Member: PHARMACOLOGY & DRUG DISCOVERY > Antimicrobial agents [ since 6 February 2007 ]
[ Biography ] [ Evaluations ]
Biography

Bambang Adiwijaya assists me with making evaluations for Faculty of 1000.

to email [Help]
Evaluations

Triphasic decline of hepatitis C virus RNA during antiviral therapy.
Dahari H, Ribeiro RM, Perelson AS
Hepatology 2007 Jul 46(1):16-21 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Varun Garg
Evaluated 22 Apr 2008

Modelling how ribavirin improves interferon response rates in hepatitis C virus infection.
Dixit NM, Layden-Almer JE, Layden TJ, Perelson AS
Nature 2004 Dec 16 432(7019):922-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Varun Garg
Evaluated 20 Feb 2007

^Top  Back to Faculty Members


© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info